MYL Mylan N.V.

Price (delayed)

$15.73

Market cap

$8.13B

P/E Ratio

29.68

Dividend/share

N/A

EPS

$0.53

Enterprise value

$20B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Highlights

MYL's P/E is 89% below its last 4 quarters average of 261.1 and 69% below its 5-year quarterly average of 95.4
The debt is down by 9% year-on-year and by 3.9% since the previous quarter
The company's quick ratio fell by 31% QoQ and by 31% YoY

Key stats

What are the main financial stats of MYL
Market
Shares outstanding
516.95M
Market cap
$8.13B
Enterprise value
$20B
Valuations
Price to earnings (P/E)
29.68
Price to book (P/B)
0.69
Price to sales (P/S)
0.71
EV/EBIT
23.18
EV/EBITDA
7.38
EV/Sales
1.74
Earnings
Revenue
$11.5B
EBIT
$862.7M
EBITDA
$2.71B
Free cash flow
$1.64B
Per share
EPS
$0.53
Free cash flow per share
$3.18
Book value per share
$22.72
Revenue per share
$22.26
TBVPS
$18.72
Balance sheet
Total assets
$30.16B
Total liabilities
$18.41B
Debt
$12.19B
Equity
$11.75B
Working capital
-$506.7M
Liquidity
Debt to equity
1.04
Current ratio
0.93
Quick ratio
0.44
Net debt/EBITDA
4.38
Margins
EBITDA margin
23.6%
Gross margin
35.6%
Net margin
2.4%
Operating margin
8%
Efficiency
Return on assets
0.9%
Return on equity
2.3%
Return on invested capital
5.2%
Return on capital employed
3.7%
Return on sales
7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MYL stock price

How has the Mylan stock price performed over time

Financial performance

How have Mylan's revenue and profit performed over time
Revenue
$11.5B
Gross profit
$4.09B
Operating income
$914.9M
Net income
$270.5M
Gross margin
35.6%
Net margin
2.4%
MYL's operating income is up by 33% YoY and by 4.4% from the previous quarter
The company's operating margin rose by 31% YoY and by 7% QoQ
The gross profit has grown by 8% YoY and by 2.3% from the previous quarter
The company's gross margin rose by 6% YoY and by 3.5% QoQ

Growth

What is Mylan's growth rate over time

Valuation

What is Mylan stock price valuation
P/E
29.68
P/B
0.69
P/S
0.71
EV/EBIT
23.18
EV/EBITDA
7.38
EV/Sales
1.74
MYL's P/E is 89% below its last 4 quarters average of 261.1 and 69% below its 5-year quarterly average of 95.4
MYL's P/B is 54% below its 5-year quarterly average of 1.5 and 14% below its last 4 quarters average of 0.8
MYL's equity is up by 4.3% since the previous quarter
The P/S is 56% below the 5-year quarterly average of 1.6 and 11% below the last 4 quarters average of 0.8

Efficiency

How efficient is Mylan business performance
The ROIC has grown by 49% YoY and by 11% from the previous quarter
MYL's ROS is up by 34% YoY and by 9% from the previous quarter

Dividends

What is MYL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYL.

Financial health

How did Mylan financials performed over time
Mylan's total assets is 64% more than its total liabilities
Mylan's current ratio has decreased by 32% YoY and by 26% from the previous quarter
The company's quick ratio fell by 31% QoQ and by 31% YoY
The debt is 3.8% greater than the equity
The debt is down by 9% year-on-year and by 3.9% since the previous quarter
The company's debt to equity fell by 8% QoQ and by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.